OMass Therapeutics

OMass Therapeutics is an Oxford, UK biotechnology company developing medicines for immunological and rare diseases. It harnesses proprietary biochemistry, native mass spectrometry and custom chemistry through its OdyssION drug discovery platform to interrogate drug targets and how they interact with their native biological ecosystem, separate from the confounding complexity of the cell. The company operates a corporate and scientific web presence (science, pipeline, publications, news and blog) and, as a therapeutics company, publishes no public developer or API surface. Backed by GV and other life-sciences investors.

OMass Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Biotechnology, Pharmaceuticals, and Drug Discovery.

OMass Therapeutics’ developer surface includes engineering blog and 2 more developer resources.

🌐 Visit website 📡 Source on GitHub
8.1/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5
0 APIs
CompanyLife SciencesBiotechnologyPharmaceuticalsDrug DiscoveryMass SpectrometryImmunologyRare Diseases

Kin Score

Kin Score Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5
Composite quality — 8.1/100 · minimal
Contract Quality 0.0 / 25
Developer Ergonomics 0.4 / 20
Commercial Clarity 0.0 / 20
Operational Transparency 0.0 / 13
Governance 0.0 / 12
Discoverability 6.8 / 10
Agent readiness — 0/100 · human only
Machine-Readable Contract 0 / 18
Agentic Access Contract 0 / 15
MCP Server 0 / 12
Machine-Readable Auth 0 / 10
Idempotency 0 / 9
Stable Error Semantics 0 / 8
Request/Response Examples 0 / 7
Rate-Limit Signaling 0 / 7
Typed Event Surface 0 / 6
Agent Skills 0 / 5
Well-Known Catalog 0 / 4
Consent & Bot Identity 0 / 3
Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/omass-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Security Posture 1

Authentication, domain security, vulnerability disclosure, and trust-center signals.

Omass Therapeutics Domain Security

TLSv1.3 · DMARC

SECURITY

Resources

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity
DomainSecurity

Company 2

The organization behind the API

Website
Website
 Blog
Blog

Source (apis.yml)

apis.yml Raw ↑ 
aid: omass-therapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/omass-therapeutics.png
name: OMass Therapeutics
description: OMass Therapeutics is an Oxford, UK biotechnology company developing medicines for immunological and rare diseases.
  It harnesses proprietary biochemistry, native mass spectrometry and custom chemistry through its OdyssION drug discovery
  platform to interrogate drug targets and how they interact with their native biological ecosystem, separate from the confounding
  complexity of the cell. The company operates a corporate and scientific web presence (science, pipeline, publications, news
  and blog) and, as a therapeutics company, publishes no public developer or API surface. Backed by GV and other life-sciences
  investors.
url: https://raw.githubusercontent.com/api-evangelist/omass-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- gv
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Life Sciences
- Biotechnology
- Pharmaceuticals
- Drug Discovery
- Mass Spectrometry
- Immunology
- Rare Diseases
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/omass-therapeutics-domain-security.yml
- type: Website
  url: https://www.omass.com
- type: Blog
  url: https://www.omass.com/blog/
x-enrichment:
  date: '2026-07-20'
  status: minimal
  artifacts_added: 1
  pass: local-v1